E & P Valuation $24.40
We have increased our probability of success for NNZ-2591 in Phelan-McDermid syndrome and other indications in the pipeline (Pitt Hopkins, Angelman, Prader-Willi). The probability of success in Phase 2 for PMS has been increased to 100%, while for the other indications this probability has been increased by 5pp.
E & P Valuation $24.40We have increased our probability of...
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.06 |
Change
-0.140(0.73%) |
Mkt cap ! $2.433B | |||
| Open | High | Low | Value | Volume |
| $18.76 | $19.35 | $18.71 | $7.893M | 414.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 5037 | $19.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.16 | 881 | 1 |
View Market Depth
| Last trade - 16.10pm 01/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$19.11 |
Change
-0.140 ( 0.78 %) |
||||
| Open | High | Low | Volume | ||
| $18.80 | $19.34 | $18.73 | 92009 | ||
| Last updated 15.59pm 01/05/2024 ? | |||||
| NEU (ASX) Chart |